Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 12:32 AM
NCT ID:
NCT06879067
Eligibility Criteria:
Inclusion Criteria:
* Men or women ages 18 to 65 years
* Healthy adults
* Ability and willingness to provide informed consent and comply with study requirements and procedures
Exclusion Criteria:
* Chronic medical disease compromising organ function
* Corticosteroids within the past month
* Pregnancy or lactating
* Inflammatory bowel disease, rheumatoid arthritis, systemic lupus erythematosus, asthma, thyroid disease, or type I diabetes
* Chronic rhinitis, deviated septum, nasal polyps, history of sinusitis treated within the past year.
* Participation in another clinical trial within the past 30 days
* Known history of drug or ETOH abuse
* Screening labs outside of the normal range; EBV IgM positive subjects with clinical signs will not receive study drug
* Nasal corticosteroids; antihistamines; nasal flu dosing within 30 days
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06879067
Study Brief:
Protocol Section:
NCT06879067